CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,791,849 | $1,391,443 | $3,018,940 | $7,389,372 |
| Dep. & Amort. | $757,717 | $753,276 | $631,231 | $630,848 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$78,906 | $98,125 | $118,181 | $138,129 |
| Change in WC | $0 | -$205,916 | $0 | -$3,661,109 |
| Other Non-Cash | -$3,014,823 | $1,271,521 | -$2,343,604 | -$1,314,929 |
| Operating Cash Flow | $455,837 | $3,308,449 | $1,424,748 | $3,144,602 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,318,428 | -$2,123,229 | -$648,891 | -$886,919 |
| Net Acquisitions | $0 | -$163,310 | $0 | -$15,862 |
| Inv. Purchases | $0 | -$2,414,163 | $0 | -$400,739 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $647,853 |
| Other Inv. Act. | $1,000,785 | $2,520,029 | -$1,483,504 | $392,486 |
| Investing Cash Flow | -$317,643 | -$2,180,673 | -$2,132,395 | -$263,181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$57,284 | $30,165 | -$85,921 | $0 |
| Stock Issued | $376 | $127 | $0 | -$60,617 |
| Stock Repurch. | -$38,269 | $352,998 | -$379,487 | -$243,806 |
| Dividends Paid | $0 | -$1,848,130 | -$1,531,128 | -$1,583,909 |
| Other Fin. Act. | $73,697 | $623,849 | -$291,072 | $200,950 |
| Financing Cash Flow | -$21,481 | -$3,154,584 | -$2,287,608 | -$1,382,959 |
| Forex Effect | $122,361 | -$1,222 | $1,314 | -$1,041 |
| Net Chg. in Cash | $239,074 | -$7,491,833 | $8,054,003 | $1,555,123 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $817,509 | $7,491,833 | $0 | $8,928,965 |
| End Cash | $1,056,583 | $0 | $7,491,833 | $10,484,087 |
| Free Cash Flow | $289,986 | -$775,858 | $775,858 | $1,957,440 |